Please login to the form below

Not currently logged in
Email:
Password:

Lupin names chief corporate development officer

Theresa Stevens has experience at Novartis and Aptalis

Lupin Theresa StevensLupin has appointed Theresa Stevens as chief corporate development officer for its global operations.

Stevens joins the India-based pharma company from Aptalis Pharma, where she was chief corporate development officer for mergers and acquisitions, strategy and global business development.

Prior to this Steven spent nine years at Novartis, serving in such roles as head of global business development and licensing.

She holds degrees in both biochemisty and law, and has previously worked as a research scientist at Dupont and as a lawyer at Pennie & Edmonds.

Lupin's decision to hire Stevens follows its appointment earlier this year of Teva's Dr Maurice Chagnaud as president, Europe, and head of inhalation strategy.

According to the company, these hires are part of a push to expand the company beyond its home market by improving its performance in the US, Europe and key emerging markets.

25th April 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cegedim Health Data

Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...